Skip to main content
Log in

IL-17A suppresses and curcumin up-regulates Akt expression upon bleomycin exposure

  • Short Communication
  • Published:
Molecular Biology Reports Aims and scope Submit manuscript

Abstract

Pro-inflammatory cytokine IL-17A modulates the expression of Akt in bleomycin (BLM) administered alveolar basal epithelial cells, the mechanism behind which remains unclear. This investigation was carried out to assess IL-17A mediated down-regulation of Akt expression and the pivotal role of curcumin as a regulatory molecule. Alveolar basal epithelial cells were treated with BLM and IL-17A and curcumin was administered as an intervention to regulate the BLM-induced oxidative damage. Cell proliferation was evaluated by clonogenic assay. Akt phosphorylation and total Akt expressions were studied using western blot analysis. Cell proliferation reduced upon treatment with BLM and this phenomenon was reversed in cells upon administration with curcumin. Administrations of BLM and IL-17A to the alveolar basal epithelial cells showed significant down-regulation of Akt expression which was reversed by treatment with curcumin. BLM and IL-17A mediated inflammation was intervened effectively with curcumin. Results of this study suggest the probable use of curcumin as an anti-inflammatory therapeutic for lung injury.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3

References

  1. Matthay MA, Zimmerman GA, Esmon C, Bhattacharya J, Coller B, Doerschuk CM et al (2003) Future research directions in acute lung injury: summary of a National Heart, Lung, and Blood Institute working group. Am J Res Crit Care Med 167(7):1027–1035

    Article  Google Scholar 

  2. Grommes J, Soehnlein O (2011) Contribution of neutrophils to acute lung injury. ‎Mol Med 17(3–4):293

    PubMed  CAS  Google Scholar 

  3. McElroy MC, Kasper M (2004) The use of alveolar epithelial type I cell-selective markers to investigate lung injury and repair. Eur Respir J 24(4):664–673

    Article  PubMed  CAS  Google Scholar 

  4. Williamson JD, Sadofsky LR, Hart SP (2015) The pathogenesis of bleomycin-induced lung injury in animals and its applicability to human idiopathic pulmonary fibrosis. Exp Lung Res 41(2):57–73

    Article  PubMed  CAS  Google Scholar 

  5. Wilson MS, Madala SK, Ramalingam TR, Gochuico BR, Rosas IO, Cheever AW et al (2010) Bleomycin and IL-1β-mediated pulmonary fibrosis is IL-17A dependent. J Exp Med 207(3):535–552

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  6. Gasse P, Riteau N, Vacher R, Michel ML, Fautrel A, Di Padova F et al (2011) IL-1 and IL-23 mediate early IL-17A production in pulmonary inflammation leading to late fibrosis. PLoS ONE 6(8):e23185

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  7. Wei X, Han J, Chen ZZ, Qi BW, Wang GC, Ma YH et al (2010) A phosphoinositide 3-kinase-γ inhibitor, AS605240 prevents bleomycin-induced pulmonary fibrosis in rats. Biochem Biophys Res Commun 397(2):311–317

    Article  PubMed  CAS  Google Scholar 

  8. Bhandary YP, Shetty SK, Marudamuthu AS, Ji HL, Neuenschwander PF, Boggaram V et al (2013) Regulation of lung injury and fibrosis by p53-mediated changes in urokinase and plasminogen activator inhibitor-1. Am J Pathol 183(1):131–143

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  9. Aggarwal BB, Harikumar KB (2009) Potential therapeutic effects of curcumin, the anti-inflammatory agent, against neurodegenerative, cardiovascular, pulmonary, metabolic, autoimmune and neoplastic diseases. Int J Biochem Cell Biol 41(1):40–59

    Article  PubMed  CAS  Google Scholar 

  10. Zhang Y, Liang D, Dong L, Ge X, Xu F, Chen W et al (2015) Anti-inflammatory effects of novel curcumin analogs in experimental acute lung injury. Resp Res 16(1):43

    Article  CAS  Google Scholar 

  11. Venkatesan N, Punithavathi V, Chandrakasan G (1997) Curcumin protects bleomycin-induced lung injury in rats. Life Sci 61(6):A51-A58

    Article  Google Scholar 

  12. Lee VY, Schroedl C, Brunelle JK, Buccellato LJ, Akinci OI, Kaneto H et al (2005) Bleomycin induces alveolar epithelial cell death through JNK-dependent activation of the mitochondrial death pathway. Am J Physiol Lung Cell Mol Physiol 289(4):L521–L528

    Article  CAS  Google Scholar 

  13. Martin TR, Hagimoto N, Nakamura M, Matute-Bello G (2005) Apoptosis and epithelial injury in the lungs. Proc Am Thorac Soc 2(3):214–220

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  14. Smith MR, Gangireddy SR, Narala VR, Hogaboam CM, Standiford TJ, Christensen PJ et al (2010) Curcumin inhibits fibrosis-related effects in IPF fibroblasts and in mice following bleomycin-induced lung injury. Am J Physiol Lung Cell Mol Physiol 298(5):L616–L625

    Article  CAS  Google Scholar 

  15. Liu Y (2015) Type II cells as progenitors in alveolar repair, lung stem cells in the epithelium and vasculature. Stem Cell Biol Regen Med. https://doi.org/10.1007/978-3-319-16232-4$42

    Article  Google Scholar 

  16. Kshirsagar S, Riedl M, Billing H, Tönshoff B, Thangavadivel S, Steuber C et al (2014) AKT-dependent enhanced migratory capacity of Th17 cells from children with lupus nephritis. J Immunol 193(10):4895–4903

    Article  PubMed  CAS  Google Scholar 

  17. Lu Y, Parkyn L, Otterbein LE, Kureishi Y, Walsh K, Ray A et al (2001) Activated Akt protects the lung from oxidant-induced injury and delays death of mice. J Exp Med 193(4):545–550

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  18. Brunet A, Bonni A, Zigmond MJ, Lin MZ, Juo P, Hu LS et al (1999) Akt promotes cell survival by phosphorylating and inhibiting a Forkhead transcription factor. Cell 96(6):857–868

    Article  PubMed  CAS  Google Scholar 

  19. Wang A, Wang J, Zhang H, Zhang S, Xu Z, Li X (2017) Curcumin inhibits the development of non-small cell lung cancer by inhibiting autophagy and apoptosis. Exp Ther Med 14(5):5075–5080

    PubMed  PubMed Central  Google Scholar 

  20. Gouda MM, Bhandary YP (2018) Curcumin down-regulates IL-17A mediated p53-fibrinolytic system in bleomycin induced acute lung injury in vivo. J Cell Biochem. https://doi.org/10.1002/jcb.27026

    Article  PubMed  Google Scholar 

Download references

Acknowledgements

Authors would like to acknowledge the financial support rendered by Yenepoya University.

Funding

This work is supported by funding support from Indian Council of Medical Research (Grant No: 2015-1235) and research grants from Yenepoya University.

Author information

Authors and Affiliations

Authors

Contributions

Conceived the idea and designed the experiments: YPB. Performed the experiments: MMG, AP. Data analysis and representation: MMG, AP.

Corresponding author

Correspondence to Yashodhar Prabhakar Bhandary.

Ethics declarations

Conflict of interest

The authors declare that they have no conflict of interest.

Ethical approval

This is an in vitro study using immortalized cell lines. Ethical clearance is not applicable.

Additional information

Mahesh Manjunath Gouda and Ashwini Prabhu are equal first authors.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Gouda, M.M., Prabhu, A. & Bhandary, Y.P. IL-17A suppresses and curcumin up-regulates Akt expression upon bleomycin exposure. Mol Biol Rep 45, 645–650 (2018). https://doi.org/10.1007/s11033-018-4199-3

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11033-018-4199-3

Keywords

Navigation